Currently Enrolling
Trial Physician / Study Coordinator
Douglas Remsen
Email Phone (475) 235-8118Site Name
DaVita Hartford North
675 Tower Ave., Suite 404, Hartford, CT 06112
Find other locations for this trial:
Currently Enrolling
Eligibility Criteria
About the Drug
What is involved for the patient
Target Enrollment
Up to 125 patients FSGS / TR-MCD or DN are planned to be enrolled into the study.
Estimated End Date
TBC